The pharma model is deteriorating rapidly. The public demands lower drug prices, and insurers deny coverage for more new prescription drugs. To keep money flowing, acquisitions of smaller biotech companies have been increasing, but some biotechs are learning that developing a new drug requires a lot of capital. Why doesn’t pharma prepare for the future?

The purpose of any business is to make money, but can a corporation satisfy Wall Street and benefit the public it serves? Big oil, for example, has prioritized profits resulting in high gas prices. Medical expenses often hinder patients long after they have left the hospital. Why do prescription drugs need to cost so much?

Access to HCPs has declined steadily, with about 49 percent of Physicians in the U.S. placing restrictions on visits from pharma sales reps. But according to Fierce Pharma, “more than 8 in 10 (83%) of HCPs say the content they’re getting from pharma companies is more relevant now than before COVID-19, and they likely have more time to read it. Three-quarters said they’d seen fewer patients over the past year, and 61% said they have more available time than they did pre-pandemic”. You can launch a drug digitally but..